CRISPR-Cas systems, derived from prokaryotic adaptive immune mechanisms, represent a revolutionary advancement in genetic engineering.  Historically, gene editing relied on less precise methods like zinc finger nucleases and TALENs.  The discovery of CRISPR, specifically the CRISPR-Cas9 system, offered a significantly improved platform due to its simplicity and programmability.  This system utilizes a guide RNA (gRNA) molecule, designed to target a specific DNA sequence, to direct the Cas9 nuclease enzyme to that location.  Cas9 then creates a double-strand break, triggering the cell's endogenous DNA repair mechanisms.  These mechanisms, non-homologous end joining (NHEJ) or homology-directed repair (HDR), can be exploited for gene knockout or precise gene editing, respectively.  HDR allows for the targeted insertion or replacement of genetic material, paving the way for gene therapy, disease modelling, and agricultural improvements.  While initially limited to Cas9, further research has expanded the CRISPR toolbox to encompass various Cas enzymes with differing functionalities, enhancing its versatility and potential applications.